AffiliationLaser Oncology Programme, Paterson Institute for Cancer Research, Christie Hospital (NHS) Trust, Manchester, UK.
MetadataShow full item record
AbstractThe subcellular, cellular and tissue/tumour interactions with non-toxic photosensitizing chemicals plus non-thermal visible light (photodynamic therapy (PDT) are reviewed. The extent to which endothelium/vasculature is the primary target is discussed, and the biochemical opportunities for manipulating outcome highlighted. The nature of tumour destruction by PDT lends itself to imaging outcome by MRI and PET.
CitationThe biology of photodynamic therapy. 1997, 42 (5):913-35 Phys Med Biol
JournalPhysics in Medicine and Biology
- Vascular effects of photodynamic therapy.
- Authors: Krammer B
- Issue date: 2001 Nov-Dec
- Experimental evaluation of possible side effects of intra-operative photodynamic therapy on rabbit blood vessels and nerves.
- Authors: Kübler AC, Stenzel W, Rühling M, Meul B, Fischer JH
- Issue date: 2003
- Vascular and cellular targeting for photodynamic therapy.
- Authors: Chen B, Pogue BW, Hoopes PJ, Hasan T
- Issue date: 2006
- Magnetic resonance imaging evaluation of photodynamic therapy-induced hemorrhagic necrosis in the murine M1 tumor model.
- Authors: Winsborrow BG, Grondey H, Savoie H, Fyfe CA, Dolphin D
- Issue date: 1997 Dec
- Molecular imaging and photodynamic therapy in hepatoblastoma.
- Authors: Seitz G, Fuchs J, Schaefer JF, Warmann SW
- Issue date: 2012 Jan 1